Eugeniusz J Kucharz

Publications of Eugeniusz J Kucharz

• Serum human cartilage glycoprotein-39 levels in patients with systemic lupus erythematosus.

  Authors: Dominika Wcisło-Dziadecka, Anna Kotulska, Ligia Brzezińska-Wcisło, Eugeniusz J Kucharz, Anna Lis-Swiety, Grazyna Kamińska-Wiciorek

  Polskie archiwum medycyny wewnȩtrznej. 12/2009; 119(12):777-84.

  INTRODUCTION: Human cartilage glycoprotein-39 (HC gp-39) is a protein secreted by various cells including chondrocytes. Serum HC gp-39 has been suggested to be a marker of cartilage damage. However,INTRODUCTION: Human cartilage glycoprotein-39 (HC gp-39) is a protein secreted by various cells including chondrocytes. Serum HC gp-39 has been suggested to be a marker of cartilage damage. However, inflammation involving other sites than the joints is an additional factor that increases the serum level of HC gp-39. OBJECTIVES: The aim of the study was to evaluate the usefulness of HC gp-39 determination in serum of patients with systemic lupus erythematosus (SLE) as a marker of joint involvement. PATIENTS AND METHODS: Serum HC gp-39 levels were measured in 25 patients with SLE and 22 healthy controls. SLE activity was assessed by the Systemic Lupus Erythematosus Disease Activity Index, and articular involvement by calculating the number of swollen and tender joints. The markers of inflammation (erythrocyte sedimentation rate, C-reactive protein) were determined. RESULTS: We observed an increase in HC gp-39 in SLE patients. However, there was no correlation of this parameter with disease activity, inflammatory markers (except serum gamma globulin levels), and articular involvement. CONCLUSIONS: The study suggests that increased HC gp-39 in SLE patients results mainly from inflammation and is not useful as a marker of joint involvement.

• Adiposis dolorosa with hypercholesterolemia and premature severe generalized atherosclerosis.

  Authors: Ilona Szypula, Anna Kotulska, Marta Szopa, Robert Pieczyrak, Eugeniusz J Kucharz

  Wiadomości lekarskie (Warsaw, Poland : 1960). 01/2009; 62(1):64-5.

• [Application of the Dietrych methodology in evaluation of the medical diagnostic therapeutic procedures]

  Authors: Eugeniusz J Kucharz, Anna Kotulska, Andrzej Zmysłowski

  Wiadomości lekarskie (Warsaw, Poland : 1960). 02/2006; 59(3-4):293-4.

• [Risk of atherosclerosis development in patients with systemic lupus erythematosus]

  Authors: Przemysław J Kotyla, Bogna Sliwińska-Kotyla, Maciej Lewicki, Eugeniusz J Kucharz

  Polskie archiwum medycyny wewnȩtrznej. 12/2005; 114(5):1138-43.

• [Gold salts in management of rheumatic disease]

  Authors: Michał Banaś, Eugeniusz J Kucharz

  Polskie archiwum medycyny wewnȩtrznej. 04/2005; 113(3):267-72.

• [ Ewing's sarcoma]

  Authors: Michal Banaś, Anna Kotulska, Anna Błach, Maciej Lewicki, Aleksandra Zoń-Giebel, Magdalena Olszanecka-Glinianowicz, Eugeniusz J Kucharz

  Polskie archiwum medycyny wewnȩtrznej. 12/2004; 112(5):1351-5.

• [Paget's disease]

  Authors: Michał Banaś, Sham A Cader, Anna Błach, Eugeniusz J Kucharz, Magdalena Olszanecka-Glinianowicz

  Polskie archiwum medycyny wewnȩtrznej. 08/2003; 110(1):759-63.

• [Sarcoidosis recognized since early childhood in the 18-year-old patient. Case report]

  Authors: Michał Banaś, Elzbieta Zycińska-Debska, Anna Błach, Maciej Lewicki, Eugeniusz J Kucharz

  Polskie archiwum medycyny wewnȩtrznej. 08/2003; 110(1):751-3.

• [Epidemiology of rheumatic fever]

  Authors: Katarzyna Grzanka, Eugeniusz J Kucharz

  Wiadomości lekarskie (Warsaw, Poland : 1960). 02/2003; 56(7-8):353-8.

  Rheumatic fever is a systemic inflammatory sequel of the upper respiratory tract infection with beta-hemolytic group A streptococci. The disease is characterized by joint, heart and subcutaneousRheumatic fever is a systemic inflammatory sequel of the upper respiratory tract infection with beta-hemolytic group A streptococci. The disease is characterized by joint, heart and subcutaneous tissue inflammation and the nervous system involvement. The incidence of rheumatic fever decreased in the 20th century but periodical resurgences and local epidemics were reported. The disease is still a significant health problem in developing countries.

• [The role of Chlamydia pneumoniae infection in the development of atherosclerosis in humans]

  Authors: Przemysław J Kotyla, Bogna Sliwińska-Kotyla, Eugeniusz J Kucharz

  Polskie archiwum medycyny wewnȩtrznej. 01/2003; 108(6):1239-44.